|
Alan R. Saltiel is the Mary Sue Coleman Director of the Life Sciences Institute at the University of Michigan; a professor at the Division of Molecular Medicine and Genetics at the University of Michigan Medical School; a faculty member at the Michigan Diabetes Research and Training Center; and John Jacob Abel Professor of Life Sciences, Department of Molecular and Integrative Physiology; a member of the Steering Committee Member at the Center for Advancing Research & Solutions for Society.〔(Alan Saltiel Elected to Institute of Medicine-Medicine at Michigan Fall 2005 )〕 He has served as the Director of the Life Sciences Institute since 2001.〔(Saltiel Lab - Affiliations | Life Sciences at Michigan here )〕 He is also a John Jacob Abel Collegiate Professor of the Life Sciences at the Department of Molecular & Integrative Physiology at the UM Medical School.〔(University of Michigan )〕 He holds an AB from Duke University (1975) and a Ph.D. from the University of North Carolina (1980).〔(Saltiel Lab - Faculty - Curriculum Vitae | Life Sciences at Michigan here )〕 During his doctorate studies in biochemistry at the University of North Carolina, Saltiel worked on thyroid-stimulating hormone and its relationship to thyroid cancer. As a post-doctoral fellow under Pedro Cuatrecasas in the Wellcome Research Labs, he began investigating insulin. He was Distinguished Research Fellow and Senior Director of the Department of Cell Biology at Parke-Davis Pharmaceutical Research Division (now Pfizer Global Research). In addition to having published more than 260 research papers, Saltiel holds 16 patents and has extensive experience with the FDA's testing and approval process for new drugs. Saltiel's lab researches signaling pathways in insulin action.〔(In Diabetes, a Complex of Causes - New York Times )〕 Such research is aimed at identifying the various ways in which problems with the insulin signaling pathway trigger diabetes.〔(University of Michigan: Diabetes at U of M )〕 Researchers in the lab have also uncovered new hormone signaling pathways and the role that proteins and genes play in this process.〔(University of Michigan: Diabetes at U of M )〕 These discoveries may reveal how the insulin-glucose balance necessary for the survival of the cell is lost due to obesity in those with diabetes.〔(Alan Saltiel Elected to Institute of Medicine-Medicine at Michigan Fall 2005 )〕〔(University of Michigan: Diabetes at U of M )〕 ==Awards and achievements== Saltiel has received many awards over the course of his career, including the Rosalyn Yalow Research and Development Award from the American Diabetes Association, Hirschl Award, The John Jacob Abel Award from ASPET and The Goodman and Gilman Award, also from ASPET.〔(Access to articles : Nature Reviews Drug Discovery )〕 He is a member of the Institute of Medicine and fellow of the American Association for the Advancement of Science. His work is often cited in biochemistry literature;〔(Access to articles : Nature Reviews Drug Discovery )〕 with more than 35,000 citations as of February 2014, he ranks among the most influential scientists in biology and biochemistry in the world.〔(Highly Cited Research )〕 His true dream is to star for the New York Knicks.〔http://www.in-cites.com/scientists/AlanSaltiel.html〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Alan R. Saltiel」の詳細全文を読む スポンサード リンク
|